Management of C. difficile Infection

Immediate Treatment Decisions

• The Infectious Diseases Society of America recommends oral vancomycin 125 mg four times daily for 10 days as first-line treatment for C. difficile infection, regardless of severity classification 1, 2
• The American College of Gastroenterology suggests that metronidazole is no longer recommended as first-line therapy and should only be considered in mild-to-moderate disease in younger patients with minimal risk factors 2

Critical Infection Control Measures

• The Centers for Disease Control and Prevention recommend placing patients with C. difficile infection in a private room with dedicated toilet immediately, and healthcare personnel must use gloves and gowns on entry to the room and during all patient care 1
• The Society for Healthcare Epidemiology of America advises to continue contact precautions for at least 48 hours after diarrhea resolution, or until discharge if C. difficile rates are high in the facility 1
• The World Health Organization suggests using soap and water for hand hygiene before and after patient contact, as alcohol-based hand sanitizers are less effective against C. difficile spores 1

Medication Management

• The Infectious Diseases Society of America recommends stopping the causative antibiotic immediately if clinically feasible, and switching to lower-risk agents if continued antibiotic therapy is necessary for another infection 3, 4
• The American College of Gastroenterology advises avoiding high-risk antibiotics including clindamycin, third-generation cephalosporins, fluoroquinolones, and penicillins 4
• The European Society of Clinical Microbiology and Infectious Diseases suggests not using antimotility agents or antiemetics with antimotility effects, as these prolong toxin retention and worsen outcomes 3, 2

Monitoring and Follow-Up

• The Infectious Diseases Society of America expects improvement in diarrhea within 3-5 days if treatment is effective, and monitors for resolution of fever, abdominal pain, and normalization of white blood cell count 3, 2
• The American College of Gastroenterology advises not performing repeat testing within 7 days during the same episode, as test-of-cure is not indicated 1
• The World Journal of Emergency Surgery defines recurrence as symptom reappearance within 8 weeks after treatment completion, and identifies risk factors for recurrence including continued non-C. difficile antibiotic use, concomitant acid suppression, older age, and severe underlying illness 5

Special Considerations for Nursing Facility Setting

• The Clinical Microbiology and Infection journal recommends testing all patients with diarrhea who have been hospitalized within the past 3 months, and testing should only be performed on unformed stools from symptomatic patients 6, 1, 2
• The Infectious Diseases Society of America suggests using sporicidal disinfectants for environmental cleaning in the patient's room, and focusing on high-touch surfaces and shared equipment 1

Common Pitfalls to Avoid

• The Clinical Microbiology and Infection journal advises not treating asymptomatic carriers, as a positive test without diarrhea represents colonization, not infection 6, 2
• The Infectious Diseases Society of America recommends not using metronidazole as first-line therapy, as current guidelines prioritize vancomycin or fidaxomicin 1, 2
• The Centers for Disease Control and Prevention suggest not delaying isolation pending test results, and placing patients on preemptive contact precautions if test results cannot be obtained same-day 1
• The World Health Organization advises not using alcohol-based hand sanitizer alone, as C. difficile spores require mechanical removal with soap and water 1